PATENT CLAIM ANALYSIS

Application Number: 16124026
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["702", "019000"]

Abstract:
A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining blood glucose data of the patient from a glucometer in communication with the computing device, aggregating blood glucose measurements to determine a representative aggregate blood glucose measurement associated with at least one scheduled blood glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to a portable device associated with the patient. The portable device displays the next recommended insulin dosage.

Claim (Index 1):
A method comprising:\n receiving, at data processing hardware, sequential scheduled blood glucose time intervals throughout a day from a healthcare provider computing device in communication with the data processing hardware, each scheduled blood glucose time interval associated with a corresponding adjustable time boundary that does not overlap with other time boundaries associated with the other scheduled blood glucose time intervals; obtaining, at the data processing hardware, blood glucose data of the patient, the blood glucose data including blood glucose measurements of the patient and blood glucose times associated with the blood glucose measurements; for each scheduled blood glucose time interval, aggregating, by the data processing hardware, the blood glucose measurements associated with the corresponding scheduled blood glucose time interval based on the blood glucose times to determine a corresponding representative aggregate blood glucose measurement associated with the corresponding scheduled blood glucose time interval; determining, by the data processing hardware, a next recommended carbohydrate-to-insulin ratio for the patient during a selected time interval based on the representative aggregate blood glucose measurement associated with the scheduled blood glucose time interval that occurs immediately after the selected time interval; and transmitting the next recommended carbohydrate-to-insulin ratio for the patient during the selected time interval from the data processing hardware to a patient device, the patient device executing a mobile application configured to:\n receive a number of carbohydrates consumed by the patient during the selected time interval; \n determine a recommended meal bolus for the patient based on the number of carbohydrates consumed by the patient and the next recommended carbohydrate-to-insulin ratio for the patient during the selected time; and \n transmit the recommended meal bolus to an administration device in communication with the patient device, the administration device configured to automatically dial in a number of units of insulin for the recommended meal bolus and administer the number of units of insulin for the recommended meal bolus.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 97.0
- Lexical Diversity: 2.23214
- Patent Class: 702.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15855315', '14922763', '15342606', '15942740', '14938997']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.3371978309329287
- 35 USC 102 Novelty (BERT): 0.7133378164211487
- Combined Prediction Score: 0.3748118294817507
- Mean Citation Score: 690.325874
- Max Citation Score: 786.6817599999997
- Similarity Product: 759.5381891866397

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test